RESUMEN
Previous studies show that vanadium oxides suffer from severe capacity loss during cycling in the liquid electrolyte, which has hindered their applications in electrochemical energy storage. The electrochemical instability is mainly due to chemical dissolution and structural pulverization of vanadium oxides during charge/discharge cyclings. In this study the authors demonstrate that amorphous mixed-valence vanadium oxide deposited on exfoliated carbon cloth (CC) can address these two limitations simultaneously. The results suggest that tuning the V4+ /V5+ ratio of vanadium oxide can efficiently suppress the dissolution of the active materials. The oxygen-functionalized carbon shell on exfoliated CC can bind strongly with VO x via the formation of COV bonding, which retains the electrode integrity and suppresses the structural degradation of the oxide during charging/discharging. The uptake of structural water during charging and discharging processes also plays an important role in activating the electrode material. The amorphous mixed-valence vanadium oxide without any protective coating exhibits record-high cycling stability in the aqueous electrolyte with no capacitive decay in 100 000 cycles. This work provides new insights on stabilizing vanadium oxide, which is critical for the development of vanadium oxide based energy storage devices.
RESUMEN
We studied the case of a 36-year-old female patient who self-administered about 30 ml of diquat solution (200 g/L) during a suicide attempt. She developed nausea, vomiting, dizziness, and weakness in her limbs and was admitted to the emergency department of our hospital 4 h later. The patient developed progressive swelling and pain in both calves 12 h after admission. Based on symptoms, lower limb color Doppler ultrasound, and elevated levels of myoglobin and creatine kinase, the patient was diagnosed with rhabdomyolysis caused by diquat poisoning. The patient recovered and was discharged after treatment with hemoperfusion, continuous venovenous hemodialysis, acid suppression, liver protection, low-dose glucocorticoids, etc. Rhabdomyolysis caused by diquat poisoning has not been previously reported. We attempted to analyze the mechanism of this symptom through a literature review. We recommend the routine monitoring of creatine phosphokinase (CK) and myoglobin (MYO) in patients with diquat poisoning to avoid missed diagnosis. Further, the mechanism of this poisoning symptom was discussed through the literature review.
Asunto(s)
Intoxicación , Rabdomiólisis , Adulto , Creatina Quinasa , Diquat , Femenino , Humanos , Mioglobina , Intoxicación/complicaciones , Intoxicación/terapia , Rabdomiólisis/inducido químicamente , Rabdomiólisis/diagnóstico , Rabdomiólisis/terapia , Intento de SuicidioRESUMEN
A randomized, double-blind, placebo-controlled multicenter trial was conducted in healthy Chinese infants to assess the efficacy and safety of a hexavalent live human-bovine reassortant rotavirus vaccine (HRV) against rotavirus gastroenteritis (RVGE). A total of 6400 participants aged 6-12 weeks were enrolled and randomly assigned to either HRV (n â= â3200) or placebo (n â= â3200) group. All the subjects received three oral doses of vaccine four weeks apart. The vaccine efficacy (VE) against RVGE caused by rotavirus serotypes contained in HRV was evaluated from 14 days after three doses of administration up until the end of the second rotavirus season. VE against severe RVGE, VE against RVGE hospitalization caused by serotypes contained in HRV, and VE against RVGE, severe RVGE, and RVGE hospitalization caused by natural infection of any serotype of rotavirus were also investigated. All adverse events (AEs) were collected for 30 days after each dose. Serious AEs (SAEs) and intussusception cases were collected during the entire study. Our data showed that VE against RVGE caused by serotypes contained in HRV was 69.21% (95%CI: 53.31-79.69). VE against severe RVGE and RVGE hospitalization caused by serotypes contained in HRV were 91.36% (95%CI: 78.45-96.53) and 89.21% (95%CI: 64.51-96.72) respectively. VE against RVGE, severe RVGE, and RVGE hospitalization caused by natural infection of any serotype of rotavirus were 62.88% (95%CI: 49.11-72.92), 85.51% (95%CI: 72.74-92.30) and 83.68% (95%CI: 61.34-93.11). Incidences of AEs from the first dose to one month post the third dose in HRV and placebo groups were comparable. There was no significant difference in incidences of SAEs in HRV and placebo groups. This study shows that this hexavalent reassortant rotavirus vaccine is an effective, well-tolerated, and safe vaccine for Chinese infants.
Asunto(s)
Infecciones por Enterovirus , Gastroenteritis , Infecciones por Rotavirus , Vacunas contra Rotavirus , Rotavirus , Administración Oral , Animales , Bovinos , China , Gastroenteritis/epidemiología , Humanos , Lactante , Infecciones por Rotavirus/epidemiología , Infecciones por Rotavirus/prevención & control , Vacunas contra Rotavirus/efectos adversos , Vacunación , Vacunas Atenuadas , Vacunas CombinadasRESUMEN
A Na2SO4 + H2SO4 mixed electrolyte is demonstrated for a tungsten bronze pseudocapacitive electrode. The Na2SO4 supporting salt allows a large potential window while H+ effectively suppresses phase transformation. The electrode delivers a capacitance of 860 mF cm-2 with a -0.9 V-0 V window and 98% capacitance retention over 30 000 cycles.
RESUMEN
Metal oxides have attracted renewed interest as promising electrode materials for high energy density supercapacitors. However, the electrochemical performance of metal oxide materials deteriorates significantly with the increase of mass loading due to their moderate electronic and ionic conductivities. This limits their practical energy. Herein, we perform a morphology and phase-controlled electrodeposition of MnO2 with ultrahigh mass loading of 10 mg cm-2 on a carbon cloth substrate to achieve high overall capacitance without sacrificing the electrochemical performance. Under optimum conditions, a hierarchical nanostructured architecture was constructed by interconnection of primary two-dimensional ε-MnO2 nanosheets and secondary one-dimensional α-MnO2 nanorod arrays. The specific hetero-nanostructures ensure facile ionic and electric transport in the entire electrode and maintain the structure stability during cycling. The hierarchically structured MnO2 electrode with high mass loading yields an outstanding areal capacitance of 3.04 F cm-2 (or a specific capacitance of 304 F g-1) at 3 mA cm-2 and an excellent rate capability comparable to those of low mass loading MnO2 electrodes. Finally, the aqueous and all-solid asymmetric supercapacitors (ASCs) assembled with our MnO2 cathode exhibit extremely high volumetric energy densities (8.3 mWh cm-3 at the power density of 0.28 W cm-3 for aqueous ASC and 8.0 mWh cm-3 at 0.65 W cm-3 for all-solid ASC), superior to most state-of-the-art supercapacitors.
RESUMEN
Here we demonstrate a controlled two-step partial exfoliation method to synthesize functionalized exfoliated graphite substrates. Ultrathin and functionalized graphene sheets anchoring on the graphite provide a large conductive surface area for loading pseudo-capacitive MnO2 nanosheets. The functionalized exfoliated graphite/MnO2 electrode achieved an excellent areal capacitance of 244 mF cm(-2), corresponding to an estimated MnO2 based gravimetric capacitance of 1061 F g(-1), which is just slightly lower than its theoretical value of 1110 F g(-1). More importantly, the seamless integration of graphene sheets and the graphite substrate minimizes the contact resistance, and substantially improves the rate capability of pseudo-capacitive materials. The electrode retained 44.8% of its capacitance when the charging current density increased 50 times from 0.23 to 11.5 mA cm(-2). This novel functionalized exfoliated graphite substrate serves as a promising supporting material that could address the relatively low electrical conductivity of various pseudo-capacitive materials, and increase the mass loading and rate capability of pseudo-capacitors.